A call for increased inclusivity and global representation in pharmacogenetic testing
Open Access
- 22 February 2024
- journal article
- research article
- Published by Springer Nature in npj Genomic Medicine
- Vol. 9 (1) , 1-4
Abstract
Commercial pharmacogenetic testing panels capture a fraction of the genetic variation underlying medication metabolism and predisposition to adverse reactions. In this study we compared variation in six pharmacogenes detected by whole genome sequencing (WGS) to a targeted commercial panel in a cohort of 308 individuals with family history of pediatric heart disease. In 1% of the cohort, WGS identified rare variants that altered the interpretation of metabolizer status and would thus prevent potential errors in gene-based dosing.Keywords
All Related Versions
Funding Information
- Sick Kids Foundation
This publication has 22 references indexed in Scilit:
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal SymptomsClinical Pharmacology & Therapeutics, 2022
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateClinical Pharmacology & Therapeutics, 2022
- Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene VariationClinical Pharmacology & Therapeutics, 2021
- Comprehensive Allele Genotyping in Critical Pharmacogenes Reduces Residual Clinical Risk in Diverse PopulationsClinical Pharmacology & Therapeutics, 2021
- Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care SettingJAMA Network Open, 2021
- Pharmacogenetics at Scale: An Analysis of the UK BiobankClinical Pharmacology & Therapeutics, 2020
- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory DrugsClinical Pharmacology & Therapeutics, 2020
- Recommendations for Clinical CYP2C9 Genotyping Allele SelectionThe Journal of Molecular Diagnostics, 2019
- Structural variation at the CYP2C locus: Characterization of deletion and duplication allelesHuman Mutation, 2019
- Recommendations for Clinical CYP2C19 Genotyping Allele SelectionThe Journal of Molecular Diagnostics, 2018